The BET protein inhibitor JQ1 is known to attenuate inflammation, oxidative stress, fibrosis and in general, to improve the skeletal muscle status in experimental cancer cachexia [18], DMD [19] and sarcopenia of aging (unpublished data). The gene discussed is DNER; the disease is cancer.